Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis
收藏Mendeley Data2026-04-18 收录
官方服务:
资源简介:
supplementary material
应用场景:
创建时间:
2023-11-10
相关数据集
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Real-world data on guselkumab, especially at times >6 months, are limited. We performed a longitudinal, retrospective analysis on 307 patients with moderate–severe chronic plaque psoriasis (Psorias
DataCite Commons2023-01-25 更新140
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
DataCite Commons2025-05-01 更新80
Anti-vascular endothelial growth factor included in this meta-analysis.
Anti-vascular endothelial growth factor included in this meta-analysis.
Figshare2015-12-02 更新60
Summary of clinical outcomes of studies included in the systematic review and meta-analyses.
Summary of clinical outcomes of studies included in the systematic review and meta-analyses.
NIAID Data Ecosystem110
Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis
Abstract Pseudomonas aeruginosa is the leading cause of nosocomial infections with high mortality rates owing to the limited therapeutic options for multidrug-resistant Pseudomonas aeruginosa (MDRPA)
Figshare2018-08-01 更新70



